Levetiracetam-induced interstitial lung disease in a patient with advanced lung cancer

Respiratory Medicine Case Reports - Tập 31 - Trang 101241 - 2020
Shintaro Sato1, Tomohiro Oba1, Hiroki Ohta1, Yuta Tsukahara1, Gen Kida1, Emiri Tsumiyama1, Kenji Kusano1, Tomotaka Nishizawa1, Rie Kawabe1, Hideaki Yamakawa1, Keiichi Akasaka1, Masako Amano1, Hidekazu Matsushima1
1Department of Respiratory Medicine, Saitama Red Cross Hospital, Saitama, Japan

Tài liệu tham khảo

Abou-Khalil, 2008, Levetiracetam in the treatment of epilepsy, Neuropsychiatric Dis. Treat., 4, 507, 10.2147/NDT.S2937 2012, National Institute for Health and Care excellence epilepsies: diagnosis and management, Clinical Guideline Shih, 2016, Epilepsy treatment in adults and adolescents: expert opinion, Epilepsy Behav., 69, 186, 10.1016/j.yebeh.2016.11.018 Glantz, 2000, Practice parameter: anticonvulsant prophylaxis in patients with newly diagnosed brain tumors. Report of the Quality Standards Subcommittee of the American Academy of Neurology, Neurology, 54, 1886, 10.1212/WNL.54.10.1886 Mikkelsen, 2010, The role of prophylactic anticonvulsants in the management of brain metastases: a systematic review and evidence-based clinical practice guideline, J. Neuro Oncol., 96, 97, 10.1007/s11060-009-0056-5 Soffietti, 2017, Diagnosis and treatment of brain metastases from solid tumors: guidelines from the European Association of Neuro-Oncology (EANO), Neuro Oncol., 19, 162, 10.1093/neuonc/now241 Yeap, 2018, Postcranioplasty seizures following decompressive craniectomy and seizure prophylaxis: a retrospective analysis at a single institution, J. Neurosurg., 131, 936, 10.3171/2018.4.JNS172519 Goldlust, 2012, Seizure prophylaxis and melanoma brain metastases, J. Neuro Oncol., 108, 109, 10.1007/s11060-012-0802-y Cereghino, 2000, Levetiracetam for partial seizures: results of a double-blind, randomized clinical trial, Neurology, 55, 236, 10.1212/WNL.55.2.236 Fagan, 2017, Levetiracetam-induced eosinophilic pneumonia, BMJ Case Rep., 10.1136/bcr-2016-219121 Angle, 1997, Bronchiolitis obliterans with organizing pneumonia and cold agglutinin disease associated with phenytoin hypersensitivity syndrome, Chest, 112, 1697, 10.1378/chest.112.6.1697 Tamada, 2009, Secondary bronchiolitis obliterans organizing pneumonia in a patient with carbamazepine-induced hypogammaglobulinemia, BMJ Case Rep. Ramírez Olivencia, 2007, Bronchiolitis obliterans organizing pneumonia induced by carbamazepine, Med. Clin., 128, 198, 10.1016/S0025-7753(07)72534-4 Annoh Gordon, 2019, A case report of phenytoin-induced eosinophilic pneumonia, Respir Med Case Rep, 28, 100922 Banka, 2002, Bronchiolitis obliterans and organizing pneumonia caused by carbamazepine and mimicking community acquired pneumonia, Postgrad. Med., 78, 621, 10.1136/pmj.78.924.621 Orliaguet, 1998, Acute eosinophilic pneumonia due to hypersensitivity to carbamazepine, Rev. Mal. Respir., 15, 797 Milesi-Lecat, 1997, Lupus and pulmonary nodules consistent with bronchiolitis obliterans organizing pneumonia induced by carbamazepine, Mayo Clin. Proc., 72, 1145, 10.4065/72.12.1145 Shibuya, 2015, DIHS/DRESS with remarkable eosinophilic pneumonia caused by zonisamide, Acta Derm. Venereol., 95, 229, 10.2340/00015555-1863 Ghandourah, 2016, Bronchiolitis obliterans organizing pneumonia associated with anticonvulsant hypersensitivity syndrome induced by lamotrigine, BMJ Case Rep., 10.1136/bcr-2014-207182 Uji, 2005, Carbamazepine-induced pneumonitis definitively diagnosed by accidental readministration, Nihon Kokyuki Gakkai Zasshi, 43, 150 Okamoto, 2009, A case of drug-induced interstitial pneumonia due to phenytoin, Nihon Kokyuki Gakkai Zasshi, 47, 758 Taweesedt, 2019, Pulmonary manifestations of drug reaction with eosinophilia and systemic symptoms (DRESS) syndrome: a systematic review, BioMed Res. Int., 10.1155/2019/7863815 Skeoch, 2018, Drug-induced interstitial lung disease: a systematic review, Clin. Med., 7 Maschio, 2012, Brain tumor-related epilepsy, Curr. Neuropharmacol., 10, 124, 10.2174/157015912800604470 Pulman, 2013, Antiepileptic drugs as prophylaxis for post-craniotomy seizures, Cochrane Database Syst. Rev., 28, CD007286 Kamenova, 2019, Prophylactic antiepileptic treatment with levetiracetam for patients undergoing supratentorial brain tumor surgery: a two-center matched cohort study, Neurosurg. Rev. Chen, 2019, Congress of neurological Surgeons systematic review and evidence-based guidelines on the role of prophylactic anticonvulsants in the treatment of adults with metastatic brain tumors, Neurosurgery, 84, E195, 10.1093/neuros/nyy545 Patsalos, 2000, Pharmacokinetic profile of levetiracetam: toward ideal characteristics, Pharmacol. Ther., 85, 77, 10.1016/S0163-7258(99)00052-2 Thiessen, 2010, A phase I/II trial of GW572016 (lapatinib) in recurrent glioblastoma multiforme: clinical outcomes, pharmacokinetics and molecular correlation, Canc. Chemother. Pharmacol., 65, 353, 10.1007/s00280-009-1041-6 Vecht, 2014, Seizure prognosis in brain tumors: new insights and evidence-based management, Oncol., 19, 751, 10.1634/theoncologist.2014-0060 Bénit, 2016, Seizures and cancer: drug interactions of anticonvulsants with chemotherapeutic agents, tyrosine kinase inhibitors and glucocorticoids, Neurooncol Pract, 3, 245